Literature DB >> 15168166

Miliary tuberculosis after infliximab therapy in Lebanon.

Imad Uthman, Nadim Kanj, Jinane El-Sayad, Abdul-Rahman Bizri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15168166     DOI： 10.1007/s10067-004-0873-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  6 in total

1.  Epidemiology of tuberculosis in Lebanon.

Authors:  W K Kalaajieh
Journal:  Int J Tuberc Lung Dis       Date:  1999-09       Impact factor: 2.373

Review 2.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

3.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

Review 4.  Tuberculosis in the cytokine era: what rheumatologists need to know.

Authors:  Carol Dukes Hamilton
Journal:  Arthritis Rheum       Date:  2003-08

5.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

6.  Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

Authors:  Juan J Gómez-Reino; Loreto Carmona; Vicente Rodríguez Valverde; Emilio Martín Mola; Maria Dolores Montero
Journal:  Arthritis Rheum       Date:  2003-08
  6 in total
  3 in total

1.  The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors:  Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

Review 2.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

Review 3.  Miliary tuberculosis: A new look at an old foe.

Authors:  Surendra K Sharma; Alladi Mohan; Animesh Sharma
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-03-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.